These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity. Zhao M, Zhang T, Li G, Qiu F, Sun Y, Zhao L. Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397 [Abstract] [Full Text] [Related]
11. Is 2-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproate, responsible for valproate-induced hyperammonemia? Kondo T, Ishida M, Kaneko S, Hirano T, Otani K, Fukushima Y, Muranaka H, Koide N, Yokoyama M, Nakata S. Epilepsia; 1992 Aug; 33(3):550-4. PubMed ID: 1350534 [Abstract] [Full Text] [Related]
13. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults. König SA, Schenk M, Sick C, Holm E, Heubner C, Weiss A, König I, Hehlmann R. Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231 [Abstract] [Full Text] [Related]
16. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. III. Influence of fasting. Löscher W, Wahnschaffe U, Hönack D, Drews E, Nau H. Epilepsy Res; 1993 Dec; 16(3):183-94. PubMed ID: 8119269 [Abstract] [Full Text] [Related]
17. Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy. Hynynen J, Pokka T, Komulainen-Ebrahim J, Myllynen P, Kärppä M, Pylvänen L, Kälviäinen R, Sokka A, Jyrkilä A, Lähdetie J, Haataja L, Mäkitalo A, Ylikotila P, Eriksson K, Haapala P, Ansakorpi H, Hinttala R, Vieira P, Majamaa K, Rantala H, Uusimaa J. Epilepsia; 2018 Nov; 59(11):2125-2136. PubMed ID: 30255931 [Abstract] [Full Text] [Related]
18. Fatal liver failure in 16 children with valproate therapy. Scheffner D, König S, Rauterberg-Ruland I, Kochen W, Hofmann WJ, Unkelbach S. Epilepsia; 1988 Nov; 29(5):530-42. PubMed ID: 3137017 [Abstract] [Full Text] [Related]
19. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS. Werner T, Treiss I, Kohlmueller D, Mehlem P, Teich M, Longin E, Gerstner T, Koenig SA, Schulze A. Epilepsia; 2007 Jan; 48(1):72-6. PubMed ID: 17241210 [Abstract] [Full Text] [Related]
20. Valproic acid hepatic fatalities. III. U.S. experience since 1986. Bryant AE, Dreifuss FE. Neurology; 1996 Feb; 46(2):465-9. PubMed ID: 8614514 [Abstract] [Full Text] [Related] Page: [Next] [New Search]